Find a UK-based prescribing clinician for medical cannabis.
The Pharmacokinetics of Cannabis
- THC is rapidly absorbed through inhalation (peak plasma levels within minutes) and more slowly via oral route (peak at one to three hours)
- THC is highly lipophilic and distributes rapidly into fat tissue, brain, and other organs, creating a reservoir that prolongs detection beyond the period of active effects
- The primary active metabolite, 11-hydroxy-THC, is responsible for much of the psychoactive effect of oral cannabis and also accumulates in fat tissue
- The inactive metabolite 11-nor-9-carboxy-THC (THC-COOH) is the primary target of urine drug testing and persists for significantly longer than THC itself
Understanding the pharmacokinetics of cannabis is essential for patients navigating drug testing, driving restrictions, and clinical management, as the detection window varies enormously depending on the method and context.
Detection Windows by Test Type
- Blood testing detects THC for one to two days in occasional users and up to seven days in heavy regular users; it is the most relevant measure of recent impairment
- Urine testing detects THC-COOH for three to four days in occasional users, up to ten days in regular users, and potentially thirty or more days in daily heavy users
- Hair follicle testing can detect cannabis metabolites for up to ninety days, though this method is rarely used in UK clinical or workplace contexts
- Oral fluid (saliva) testing detects THC for twelve to twenty-four hours in most users and is increasingly used by UK police for roadside drug testing
Drug testing windows vary significantly by detection method, frequency of use, and individual metabolism, meaning that patients cannot rely on general rules and must understand the specific test being applied to them.
Factors That Affect How Long Cannabis Stays in Your System
- Body fat percentage significantly affects retention time; higher body fat stores more THC and extends the detection window, particularly in urine
- Frequency and dose of use are the strongest predictors of detection time; daily medical cannabis users will have much longer detection windows than occasional users
- Individual variation in CYP2C9 and UGT enzyme activity affects THC metabolism rate and can cause significant differences in clearance time between patients
- Route of administration influences onset and peak but not total clearance time significantly; oral and inhaled cannabis clear at similar rates once absorbed
Individual factors — particularly body fat and frequency of use — create wide variation in detection times, making it impossible to give a single reliable answer without knowing the individual’s specific circumstances.
Practical Implications for Medical Patients
- Patients who drive should understand that impairment from THC dissipates within four to six hours for most inhaled doses, but legal zero-tolerance limits mean blood can test positive beyond the period of impairment
- Workplace drug testing poses a real risk for prescribed cannabis patients; employer notification and a copy of the prescription may protect against disciplinary action depending on company policy
- For pre-employment drug testing, patients must disclose their prescription and check whether the employer’s policy accommodates prescribed controlled medicines
- Cannabis clearance before planned procedures or periods of increased legal scrutiny is achievable with planned cessation, but requires at least seven to fourteen days for infrequent users and longer for daily users
Medical cannabis patients need clear guidance on detection windows from their prescribing clinician, particularly in relation to driving, workplace testing, and any legal or professional obligations, to avoid inadvertent consequences.